Patients on these combination regimens may require dose adjustments of concurrent diabetes medications to prevent low blood sugar episodes
announced promising preclinical data for its oral compound TIX100, which effectively prevents weight regain in mice after the cessation of GLP-1 treatment, specifically semaglutide
In AWARD-10 [31], a 24-week, randomized, double-blind, placebo-controlled trial evaluating once-weekly dulaglutide (administered at either 1.5 or 0.75 mg) as add-on therapy to SGLT2is in a total of 424 patients with inadequately controlled T2DM, only one episode of severe hypoglycemia was reported throughout the study, in a patient treated with dulaglutide 0.75 mg, confirming the very low incidence of serious hypoglycemia with GLP-1RAs in combination with SGLT2is [31]
It is used for the treatment of type 2 diabetes and associated cardiovascular complications
In addition, the present work employs the precision medicine approach [51] to define a Long COVID model which links the acute inflammation of COVID-19 with IO&NS pathways and the neuropsychiatric symptoms 34 months later
Academics looked at Danish health registries for nearly 500,000 women, of whom 529 had been taking liraglutide or semaglutide when they became pregnant